SG10202105200SA - A method for preparing a growth factors containing platelet releasate - Google Patents

A method for preparing a growth factors containing platelet releasate

Info

Publication number
SG10202105200SA
SG10202105200SA SG10202105200SA SG10202105200SA SG10202105200SA SG 10202105200S A SG10202105200S A SG 10202105200SA SG 10202105200S A SG10202105200S A SG 10202105200SA SG 10202105200S A SG10202105200S A SG 10202105200SA SG 10202105200S A SG10202105200S A SG 10202105200SA
Authority
SG
Singapore
Prior art keywords
preparing
growth factors
containing platelet
platelet releasate
factors containing
Prior art date
Application number
SG10202105200SA
Other languages
English (en)
Inventor
Theo Gooris
Hossam Mostafa Fahmy
Original Assignee
Power Of Platelets Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Power Of Platelets Pte Ltd filed Critical Power Of Platelets Pte Ltd
Publication of SG10202105200SA publication Critical patent/SG10202105200SA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/19Platelets; Megacaryocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3486Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0644Platelets; Megakaryocytes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70Enzymes
    • C12N2501/73Hydrolases (EC 3.)
    • C12N2501/734Proteases (EC 3.4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2529/00Culture process characterised by the use of electromagnetic stimulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
SG10202105200SA 2016-11-18 2017-11-20 A method for preparing a growth factors containing platelet releasate SG10202105200SA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16199628 2016-11-18

Publications (1)

Publication Number Publication Date
SG10202105200SA true SG10202105200SA (en) 2021-06-29

Family

ID=57538992

Family Applications (1)

Application Number Title Priority Date Filing Date
SG10202105200SA SG10202105200SA (en) 2016-11-18 2017-11-20 A method for preparing a growth factors containing platelet releasate

Country Status (19)

Country Link
US (1) US11786556B2 (sr)
EP (1) EP3541398B1 (sr)
JP (1) JP7210465B2 (sr)
KR (2) KR102805434B1 (sr)
CN (1) CN110267667A (sr)
AU (1) AU2017360070B2 (sr)
BR (1) BR112019010228A2 (sr)
CA (1) CA3044328A1 (sr)
ES (1) ES2980291T3 (sr)
HR (1) HRP20240919T8 (sr)
HU (1) HUE067544T2 (sr)
IL (1) IL266723B2 (sr)
MX (1) MX2019005811A (sr)
PL (1) PL3541398T3 (sr)
RS (1) RS65796B1 (sr)
SG (1) SG10202105200SA (sr)
SM (1) SMT202400279T1 (sr)
WO (1) WO2018091713A1 (sr)
ZA (1) ZA201903946B (sr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6673728B2 (ja) * 2016-03-21 2020-03-25 テルモ株式会社 血液成分分離装置および血液成分分離方法
WO2019084546A1 (en) * 2017-10-27 2019-05-02 Arteriocyte Medical Systems, Inc. INCREASE IN FERTILITY BY PLASMA RICH IN PLATELETS
US20220079987A1 (en) * 2019-01-04 2022-03-17 Direct Biologics Llc Isolation and use of autogenous platelet derived exosomes
ES2782723B2 (es) * 2019-03-13 2021-05-18 Active Bioregeneration Tech Sl Procedimiento para obtencion y conservacion de factores de crecimiento de alta pureza y sus usos
WO2021035205A1 (en) * 2019-08-22 2021-02-25 Awidi Abdalla S Method of preparing a de-fibrinated platelet lysate, and uses of said method
US12570962B2 (en) * 2020-02-03 2026-03-10 Oklahoma Blood Institute Preparation of human platelet lysate (HPL) from refrigerated whole blood platelets
US20230172989A1 (en) * 2020-03-30 2023-06-08 Estar Technologies Ltd System and a method for obtaining an improved plasma extract
CN113332312B (zh) * 2021-02-01 2023-02-24 浙江大学医学院附属邵逸夫医院 一种基于物理整粒的自成形血小板纳米囊泡及其制备方法
CN117396077A (zh) * 2021-03-10 2024-01-12 寺崎生物医学创新研究所 用于实验室生长肉和其他应用的生长因子
ES2934719A1 (es) 2021-08-24 2023-02-24 Fundacion Para La Investig E Innovacion Biosanitaria Del Principado De Asturias Finba Método para obtener un secretoma derivado de plaquetas y usos del mismo
CN114272359B (zh) * 2021-12-21 2024-06-18 青岛恩普生物技术有限公司 一种重组人血小板衍生生长因子pdgf治疗急性伤害性疼痛的应用
CN115282065B (zh) * 2022-08-11 2024-03-15 顾帅 一种含间充质干细胞外泌体的冻干粉及其制备方法和应用
CN115125191B (zh) * 2022-08-22 2023-10-13 浙江绿蔻生物技术有限公司 成纤维细胞转化培养基及其应用、成纤维细胞的制备方法
US20250360168A1 (en) * 2024-04-11 2025-11-27 Gms Capital Partners Llc Methods for making human growth factor concentrate and compositions and uses thereof

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996030532A1 (en) 1995-03-24 1996-10-03 Novartis Ag Gene therapy for transplantation and inflammatory or thrombotic conditions
CA2233031A1 (en) 1995-09-26 1997-04-03 Beth Israel Deaconess Medical Center, Inc. Gene therapy with modified p65 proteins
US5834418A (en) * 1996-03-20 1998-11-10 Theratechnologies, Inc. Process for the preparation of platelet growth factors extract
US5948407A (en) 1997-03-19 1999-09-07 Shire Laboratories Inc. Oral induction of tolerance to parenterally administered non-autologous polypeptides
WO2000044398A2 (en) 1999-01-28 2000-08-03 Board Of Regents, The University Of Texas System Methods for increasing circulating platelets for collection and cryopreservation using thrombopoietin compositions
WO2008034803A1 (en) * 2006-09-18 2008-03-27 Medizinische Universität Graz Plasma-free platelet lysate for use as a supplement in cell cultures and for the preparation of cell therapeutics
EP2077118A1 (en) 2008-01-07 2009-07-08 Gwo Rei Biomedical Technology Corp. Clottable concentrate of platelet growth factors and preparation method thereof
US8734854B2 (en) * 2009-07-09 2014-05-27 Orogen Biosciences Inc. Process for removing growth factors from platelets
WO2011088231A1 (en) 2010-01-13 2011-07-21 Apt Therapeutics, Inc. Apyrase therapy for bleeding conditions
ES2402144T3 (es) * 2010-05-25 2013-04-29 Gwowei Technology Co., Ltd. Lisado plaquetario inactivado que contiene factores de crecimiento empobrecido en PDGF y VEGF y su procedimiento de preparación
IL210162A0 (en) 2010-12-21 2011-03-31 Omrix Biopharmaceuticals Viral inactivated platelet extract, use and preparation thereof
US20120321722A1 (en) * 2011-05-17 2012-12-20 Qiyong Peter Liu Platelet Storage and Reduced Bacterial Proliferation In Platelet Products Using A Sialidase Inhibitor
ITRM20110500A1 (it) 2011-09-23 2013-03-24 Futura Stem Cells Sa Lisato piastrinico, usi di esso e metodo per la sua preparazione
US9682104B2 (en) 2012-01-26 2017-06-20 Jadi Cell Llc Lyophilized platelet lysates
US9205110B2 (en) 2012-07-18 2015-12-08 Arthrex, Inc. Enhanced autologous growth factor production and delivery system
US20150224173A1 (en) * 2012-08-17 2015-08-13 Kasiak Research Pvt. Ltd. Method of preparing a growth factor concentrate derived from human platelets
CN103290129A (zh) 2013-06-05 2013-09-11 中国科学院苏州生物医学工程技术研究院 一种用于人血小板同种抗原基因的检测方法
WO2015031465A1 (en) * 2013-08-27 2015-03-05 Cook General Biotechnology Llc Bioactive compositions derivable from platelet concentrates, and methods for preparing and using same
KR20150061806A (ko) 2013-11-28 2015-06-05 중부대학교 활성화된 혈소판 풍부 혈장을 유효성분으로 포함하는 동물의 창상 치료용 수의학적 조성물
CN203763562U (zh) 2014-03-28 2014-08-13 刘凤珍 自体血液回收浓缩变温过滤系统
US20160051586A1 (en) 2014-08-21 2016-02-25 Jeremy Delk Methods of growing and preparing stem cells and methods of using the same
CN104450613A (zh) 2014-12-05 2015-03-25 黄相杰 一种利于自体骨髓间充质干细胞在体外培养的细胞培养基
EP3880217B1 (en) * 2018-11-14 2024-01-03 Onderzoeks en Ontwikkelingsfonds Rode Kruis-Vlaanderen Methods for preparing platelet releasate

Also Published As

Publication number Publication date
EP3541398B1 (en) 2024-04-10
ZA201903946B (en) 2023-04-26
JP7210465B2 (ja) 2023-01-23
EP3541398C0 (en) 2024-04-10
MX2019005811A (es) 2020-07-27
CN110267667A (zh) 2019-09-20
PL3541398T3 (pl) 2024-08-19
IL266723B2 (en) 2023-10-01
US11786556B2 (en) 2023-10-17
US20190321408A1 (en) 2019-10-24
KR20240096758A (ko) 2024-06-26
WO2018091713A1 (en) 2018-05-24
AU2017360070B2 (en) 2024-09-12
CA3044328A1 (en) 2018-05-24
SMT202400279T1 (it) 2024-09-16
IL266723A (en) 2019-07-31
BR112019010228A2 (pt) 2019-08-20
HRP20240919T1 (hr) 2024-10-11
RU2019118720A (ru) 2020-12-18
HRP20240919T8 (hr) 2024-10-25
RS65796B1 (sr) 2024-08-30
JP2020504167A (ja) 2020-02-06
EP3541398A1 (en) 2019-09-25
KR20200015440A (ko) 2020-02-12
AU2017360070A1 (en) 2019-07-04
RU2019118720A3 (sr) 2021-03-18
ES2980291T3 (es) 2024-09-30
IL266723B1 (en) 2023-06-01
KR102805434B1 (ko) 2025-05-12
HUE067544T2 (hu) 2024-11-28

Similar Documents

Publication Publication Date Title
ZA201903946B (en) A method for preparing a growth factors containing platelet releasate
IL250198B (en) Methods for preparing platelet products
IL282359A (en) Methods for the preparation of lysate from fermentations
IL250682A0 (en) A method for the preparation of 2'-o-fucosyl lactose
IL265536A (en) A method for the production of a crystalline form of the a modification of calcobuterol
GB2529517B (en) Method For Preparing A Three-Dimensional Article
GB201905146D0 (en) Method for preparing aronatic hydrocarbons
GB201507437D0 (en) Method for preparing a sorbent
PL3387375T3 (pl) Sposób tworzenia mapy głębokości
GB2541062B (en) Method for preparing a sorbent
GB2541767B (en) Method for preparing a sorbent
EP3235929A4 (en) Synthetic resin and synthetic fiber containing linolenic acid, and method for producing same
GB201409895D0 (en) Method for producing synthetic diamonds
ZA201903463B (en) Method for preparing hexadecahydropyrene
IL253884A0 (en) Pruning method to produce improved seeds
GB2541061B (en) Method for preparing a sorbent
PL3199570T3 (pl) Sposób otrzymywania kompozycji zawierającej 2-etyloheksylokrzemian
PL3524592T3 (pl) Sposób otrzymywania związku fenyloalaniny
PL3508512T3 (pl) Sposób wytwarzania poliwęglanu
PL3599903T3 (pl) Sposób wytwarzania szpuli zawierającej materiał zawierający alkaloidy
IL262151B (en) Processes for preparing oxathiazine-like compounds
HUE052132T2 (hu) Eljárás egy tartály elõállítására
GB201608366D0 (en) Hydroponic growing method
GB2527129B (en) Method for preparing a ninhydrin reagent
GB201709297D0 (en) Method for preparing methylprrolidones